April 2024 - DNA Polymerase Inhibitors drug patent information, global generic entry, market access

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rubicon	ACYCLOVIR	acyclovir	SUSPENSION;ORAL	215724-001	Aug 18, 2022	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Carlsbad	ACYCLOVIR	acyclovir	TABLET;ORAL	075382-002	Apr 30, 1999	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Heritage Pharms	ACYCLOVIR	acyclovir	TABLET;ORAL	074891-001	Oct 31, 1997	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Hetero Labs Ltd V	ACYCLOVIR	acyclovir	TABLET;ORAL	203834-002	Oct 29, 2013	AB	RX	No	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Apotex Inc	ACYCLOVIR	acyclovir	TABLET;ORAL	077309-002	Sep 29, 2005	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Yiling	ACYCLOVIR	acyclovir	CAPSULE;ORAL	212173-001	Sep 14, 2020	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	ACYCLOVIR	acyclovir	TABLET;ORAL	204314-001	Aug 19, 2014	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration